Skip to main content

Table 1 Comparison of clinicopathological features with HER-2 status using CISH, qRT-PCR (qPCR), and IHC.

From: Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma

Variables (n)a

CISH

P *

qPCR

P *

IHC

P *

 

≤ 5

>10

 

≤ 2.00

>2.00

 

0/1+

2/3+

 

Age (years)

         

≤ 50 (28)

9

5

0.9541

15

13

0.2569

17

11

0.3651

>50 (48)

15

8

 

32

16

 

34

14

 

Lymph node status

         

<4 (57)

21

9

0.1756

38

19

0.0915

40

17

0.4723

≥ 4 (32)

3

4

 

8

10

 

11

7

 

ND (1)

0

0

 

0

1

 

0

1

 

Tumor Size (cm)

         

0 – 2 (19)

5

5

0.1883

10

9

0.2953

11

8

0.2745

>2 (56)

19

7

 

37

19

 

40

16

 

ND (1)

0

1

 

0

1

 

0

1

 

Clinical Stage

         

I/IIA/IIB (65)

21

9

0.1756

41

24

0.5901

44

21

0.7912

IIIA/IIIB (11)

3

4

 

6

5

 

7

4

 

Histologic grade

         

I/II (36)

10

6

1.000

22

14

0.9237

23

13

0.6767

III (35)

10

6

 

21

14

 

24

11

 

ND (5)

4

1

 

4

1

 

4

1

 

Ki-67 status

         

Low (≤ 25%) (32)

11

6

0.5133

19

13

0.5354

21

11

0.7209

High (> 25%) (31)

8

7

 

16

15

 

19

12

 

Not reactive (13)

5

0

 

12

1

 

11

2

 

Familial History of Cancer

         

Yes (15)

4

3

0.6346

7

8

0.1769

10

5

0.9678

No (61)

20

10

 

40

21

 

41

20

 
  1. a Number of the cases evaluated by qRT-PCR and IHC, while 37 cases were evaluated using CISH.
  2. * Chi-Square test.
  3. ND: not determined.